Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
19.80
-0.37 (-1.83%)
At close: Mar 3, 2026, 4:00 PM EST
20.63
+0.83 (4.19%)
After-hours: Mar 3, 2026, 4:10 PM EST
Apollomics Market Cap
Apollomics has a market cap or net worth of $42.49 million as of March 3, 2026. Its market cap has increased by 280.80% in one year.
Market Cap
42.49M
Enterprise Value
41.14M
1-Year Change
280.80%
Ranking
Category
Stock Price
$19.80
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $42.49M, a decrease of -67.21%. That is a compound annual growth rate of -23.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 43.29M | 7.89% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrivon Therapeutics | 48.28M |
| Estrella Immunopharma | 47.92M |
| Klotho Neurosciences | 47.48M |
| NextCure | 43.89M |
| Aligos Therapeutics | 42.86M |
| Telomir Pharmaceuticals | 42.63M |
| Veru Inc. | 42.05M |
| Impact BioMedical | 41.93M |